Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
52.79+1.95 (+3.84%)
At close: 04:00PM EST
52.86 +0.07 (+0.13%)
After hours: 06:13PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inverted Hammer

Inverted Hammer

Previous Close50.84
Open49.31
Bid52.60 x 900
Ask57.55 x 2200
Day's Range47.29 - 53.22
52 Week Range47.29 - 93.66
Volume1,130,596
Avg. Volume674,324
Market Cap5.518B
Beta (5Y Monthly)1.23
PE Ratio (TTM)N/A
EPS (TTM)-1.36
Earnings DateFeb 02, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est87.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ARWR

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Arrowhead Pharmaceuticals, Inc.
    ARWR: Lowering target price to $60.00ARROWHEAD PHARMACEUTICALS IN has an Investment Rating of BUY; a target price of $60.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
Advertisement
Advertisement